P526: Expanding access to hereditary cancer testing through E-visits and automated result delivery: A pilot study in an integrated health system
Abstract
Hereditary Breast and Ovarian Cancer (HBOC) and Lynch syndrome (LS) are among the most common hereditary cancer syndromes, yet many at-risk individuals remain undiagnosed due to barriers in access and identification. Southern California Permanente Medical Genetics (SCPMG) has offered genetic testing for HBOC and LS since the late 1990s; however, only about 50% of patients with HBOC (n=5,717) and 15% with LS (n=1,873) have been identified. To address this gap and expand access, we conducted a pilot study to evaluate the feasibility and impact of a scalable, technology-driven approach to hereditary cancer testing.
Fields of Study & Subjects
BRCA gene mutations in cancer
Genetic factors in colorectal cancer
Telemedicine and Telehealth Implementation
Publication details
- Journal / source
- Genetics in Medicine Open
- Volume
- 4
- Pages
- 104018–104018
- Publication date
- 1 January 2026
- Language
- EN